Compare AXON & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXON | KVUE |
|---|---|---|
| Founded | 1993 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Specialty Chemicals |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.2B | 32.9B |
| IPO Year | 2001 | 2023 |
| Metric | AXON | KVUE |
|---|---|---|
| Price | $597.29 | $19.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 11 |
| Target Price | ★ $758.80 | $19.45 |
| AVG Volume (30 Days) | 1.1M | ★ 19.0M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.82% |
| EPS Growth | N/A | ★ 40.74 |
| EPS | ★ 2.05 | 0.25 |
| Revenue | $2,779,536,000.00 | ★ $15,124,000,000.00 |
| Revenue This Year | $31.50 | $4.85 |
| Revenue Next Year | $28.95 | $2.63 |
| P/E Ratio | $291.69 | ★ $79.22 |
| Revenue Growth | ★ 33.47 | N/A |
| 52 Week Low | $339.01 | $14.02 |
| 52 Week High | $885.92 | $22.87 |
| Indicator | AXON | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 76.93 | 75.51 |
| Support Level | $557.20 | $16.83 |
| Resistance Level | $597.57 | N/A |
| Average True Range (ATR) | 29.50 | 0.35 |
| MACD | 16.50 | 0.14 |
| Stochastic Oscillator | 93.36 | 98.01 |
Axon Enterprise Inc is building a public safety operating system by integrating a suite of hardware devices and cloud software solutions. The company's suite includes cloud-hosted digital evidence management solutions, TASER energy devices, drones and robotic security, and training solutions. Its operation comprises of two operating segments, Software and Services, and Connected Devices. The company generates the majority of its revenue from the Connected Devices segment, which is engaged in developing, manufacturing, and selling fully integrated hardware solutions such as conducted energy devices sold under the TASER brand, body cameras, fixed and in-car cameras, drone and counter-drone technologies, and a broad ecosystem of accessories, extended warranties and related hardware products.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.